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ABSTRACT 
The Effect of Dietary Calcium and Phosphorus Levels 
on Audiogenic Seizure Susceptibility and 
Brain Neurotransmitters in 
Magnasium Deficient Rats 
by 
Rachaneeporn Chaistitwanich, Master of Science 
Utah State University, 1986 
Major Professor: Dr. Arthur W. Mahoney 
Department: Nutrition and Food Sciences 
The effects of dietary calcium and phosphorus levels on 
audiogenic seizure susceptibility and brain neurotransmitter 
were investigated in magnesium deficient rats. For 17 days, 
male weanling rats were fed magnesium deficient diets which 
also contained deficient (-), adequate (=}, and excess (+) 
amounts of calcium and/or phosphorus. Reduction of seizure 
incidence was seen in low calcium and/or low phosphorus 
diets. High calcium, and high calcium in combination with 
high phosphorus increased the severity of seizures. High 
calcium and low phosphorus, and high phosphorus and low 
calcium diets prevented seizuring. Most magnesium deficient 
diets resulted in elevation of serum phosphorus, calcium, 
and sodium concentrations. Within diet treatments, animals 
that seized had higher serum mineral concentrations than 
animals that failed to seize. Magnesium 
i x 
deficiency 
increased serotonin in cerebral cortex, cerebellum, and 
medulla oblongata and pons, and 5-hydroxyindoleacetic acid 
concentrations in cerebral cortex. There were no signifi-
cant diet effects in brain neurotransmitter concentrations 
in the midbrain. Calcium seemed to play an important role 
in increasing both audiogenic seizure susceptibility and 
brain neurotransmitters. However, brain neurotransmitter 
levels were not related to seizure susceptibility. Calcium 
increased serum potassium and sodium concentrations and it 
increased brain serotonin concentration overal I. Increasing 
dietary phosphorus levels increased 
decreased serum calcium concentrations, 
brain neurotransmitters. 
serum phosphorus, 
but did not affect 
(71 pages) 
INTRODUCTION AND REVIEW OF LITERATURE 
Magnesium is one of the most prevalent elements in the 
earth's crust and in sea water. It is the fourth most abun-
dant cation in the body (Rude and Singer, 1981; Wacker, 
1980). Magnesium plays an important role in many physio-
logical functions. It acts as a co-factor for enzymes 
requiring ATP. It is also involved in neuromuscular con-
traction, protein synthesis, membrane permeability and the 
electrolyte transport system (Ebel and Gunther, 1980). In 
rats, cerebrospinal fluid (CSF) magnesium concentration is 
higher than in the plasma (Chutkow, 1972, 1974, and 1978; 
Praharaj et al., 1978). 
Magnesium deficiency symptoms in man include neuromus-
cular dysfunction, behavioral disturbance, and cardiovascu-
lar abnormalities (Bronner and Coburn, 1981; Hanna et al., 
1960; Rude and Singer, 1981). Causes of magnesium defi-
ciency include gastrointestinal disorders such as protein-
calorie malnutrition, renal loss such as starvation, alco-
holism and renal diseases, and endocrine and metabolic dis-
turbances such as those that occur in hypoparathyroidism, 
hypothyroidism, hyperthyroidism and phosphate deficiency 
(Rude and Singer, 1981; Zimmet, 1968). 
In protein calorie malnutrition, which causes many syn-
dromes in humans and animals including infection, parasitic 
infestation, anemia and electrolyte derangements resulting 
from gastroenteritis and malabsorption (Caddell and Olsen, 
1973), magnesium deficiency is related to hypoproteinemia, 
2 
but protein supplementation alone could not bring serum pro-
tein concentration to normal levels. Children with protein 
calorie malnutrition who have low serum and CSF magnesium 
levels when supplemented with protein and magnesium, show 
improvements in appetite, mental condition, healing of skin 
lesions, body weight gain and serum protein. They return to 
normal magnesium concentration faster than with protein 
supplementation alone (Praharaj et al., 1978). It has been 
shown in animals that magnesium requirement is higher when 
dietary protein intake is high (Caddell and Olsen, 1973). 
Magnesium has an antagonistic reaction with calcium on 
acetylcholine release from nerve endings into the synaptic 
space (Aikawa, 1981; del Castillo and Engbaek, 1954; Ebel 
and Gunther, 1980; Mordes and Wacker, 1978; Seelig et al., 
1975). Excess magnesium reduces and blocks, and calcium 
enhances the release of acetylchloline from neuromuscular 
junctions (Aikawa, 1981; Mordes and Wacker, 1978; Rude and 
Singer, 1981; Wacker, 1980). It reduces the impulse trans-
mission across the neuromuscular junction (Fleming et al., 
1972). High magnesium is also an anesthetic of central 
nervous system depressant (Halpern, 1985a). On the other 
hand, magnesium deficiency causes a hyperexcitability of the 
central nervous system (Buck et al., 1976; Chutkow, 1974). 
The activity of + + (Na -K )-ATPase which is important in 
maintaining intracellular (Na+) at low levels, intracellular 
(K+) at high levels, and resting membrane potentials in 
3 
nervous tissue (Reuss et al., 1984; Whang, 1983) depends on 
many factors such as ATP, magnesium, sodium, potassium, cal-
cium, and inorganic phosphate concentrations. The produc-
tion of ATP depends on the functioning of the glycolytic 
pathway, the tricarboxylic acid cycle, and oxidative phos-
phorylation which also require magnesium as a co-factor for 
many enzymic reactions (Stryer, 1981). 
Magnesium concentration also affects the activity of 
(Na+-K+)-ATPase. Buck (1978) found that although the enzyme 
activity increases as magnesium concentration increases, it 
is increased by magnesium deficiency in the rat brain which 
may relate to the hyperexcitability of the animals due to 
ionic changes. Increasing the magnesium concentration 
increases the enzyme activity in magnesium deficiency (Bond 
and Hudgins, 1975; Loveless and Heaton, 1976). 
Inhibition of (Na+-K+)-ATPase has a relationship with 
intracellular (Na+) and (K+) concentrations. It increases 
with increasing (K+) and decreases with increasing (Na+) 
(Bond and Hudgins, 1975; Kuriki et al., 1976). Potassium 
ion activity on (Na+-K+)-ATPase inhibition also decreases 
with increasing magnesium ion (Bond and Hudgins, 1975) and 
pH (Huang and Askari, 1984). 
as (Na+) increases. 
The uptake of (K+) increases 
Increasing calcium at low concentration inhibits the 
activity of (Na+-K+)-ATPase (Buck, 1978). This is due to 
the formation of Ca-ATP complexes which reversibly competes 
4 
with Mg-ATP complexes. The competition of calcium at sodium 
and potassium activation sites which causes an inhibition of 
the enzyme has also been indicated (Robinson, 1974). 
The activity of (Na+-K+)-ATPase is also reduced by 
inorganic phosphate (Eisner and Richards, 1982). The appar-
ent affinity of ATP decreases as the concentration of inor-
ganic phosphate increases. This is due to inorganic phos-
phate competing with ATP at the low affinity site but not at 
the phosphorylation site (Post et al., 1975). Phosphate 
inhibition is maximum at pH 6.1 to 7.0, but it is decreased 
by increasing pH (Huang and Askari, 1984). 
Ouabain, copper, zinc (Oonaldson et al., 1972), and 
cobalt (Hunt and Craig, 1973) cause seizures in rats and 
also inhibit (Na+-K+)-ATPase activity. A ouabain-like 
compound in human CSF has been found to inhibit (Na+-K+)-
ATPase activity (Lechtstein et al., 1985). Coplon and 
Maffly (1972) found that ouabain reduced transepithelial 
sodium transport and respiration in toad bladder. In 
contrast, Kracke (1983) showed that ouabain does not inhibit 
(Na+-K+)-ATPase in guinea pig brain. The inhibition of 
copper on ATPase activity is rapid and irreversible (Prakash 
et al., 1973). 
There are also hormonal effects on (Na+-K+)-ATPase 
activity. Yoshimura (1973) has found that catecholamines, 
especially norepinephrine and dopamine, increase the enzyme 
activity in many regions of rats brain. He also showed that 
5 
although norepinephrine has been reported to increase the 
cyclic AMP concentration of rat cerebral cortex, (Na+-K+)-
ATPase activity is not affected by enhancing the formation 
of cyclic AMP. It also increased as serotonin concentration 
increases (Hernandez, 1979) but the effect is less than with 
norepinephrine or dopamine. 
Magnesium deficient rats have been suggested as an ex-
cellent model for seizure disorders and epilepsy research 
(Buck, 1978; Collins, 1972; Mahoney et al., 1983). They are 
also interesting because the effect of magnesium deficient 
is reversible by rehabilitation with dietary magnesium and 
no brain damage is found. 
6 
OBJECTIVES 
The purposes of this study were 1) to see the effect of 
different dietary levels of calcium and phosphorus in the 
diets on audiogenic seizure susceptibility of magnesium 
deficient rats. 2) to determine the effects of diets on 
serum magnesium, calcium, phosphorus, sodium and 
concentrations to determine the associations with 
potassium 
behavior. 
3) to determine dietary magnesium, calcium, and phosphorus 
effects on the brain neurotransmitters: norepinephrine (NE}, 
dopamine (DA) and its metabolites 3,4-dihydroxyphenylacetic 
acid (OUPAC) and homovanillic acid (HVA), and serotonin 
(5-HT} and its metabolite 5-hydroxyindole-3-acetic acid 
(HIAA}. 
PART I 
EFFECT OF VARYING DIETARY CALCIUM AND PHOSPHORUS 
LEVELS ON SEIZURE SUSCEPTIBILITY 




Seizure susceptibility and hyperexcitability are the 
most well-known sympto~s of magnesium deficiency. In man, 
the causes of magnesium deficiency include malabsorption 
syndrome, portal cirrhosis, acute pancreatitis, hyperthy-
roidism, hypoparathyroidism, diabetic acidosis, prolonged 
intravenous therapy, protein calorie malnutrition, phosphate 
deficiency , and alcoholism. The physical symptoms of 
magnesium deficiency in rats include reduced growth, skin 
lesions, and edema of the ears and claws. 
Several studies (Buck et al., 1976, 1978; Harriman, 
1980; Mahoney et al., 1983) have been done in animals, 
especially rats, to study seizure susceptibility of magne-
sium defici e ncy. It has been suggested that magnesium defi-
cient rats may act as a model for epilepsy (Buck et al., 
1976). Nonspecific excitability level (NEL) which is an 
indicator of central nervous system excitability and audio-
genic sei zure susceptibility relate to each other except 
when serum magnesium concentration is very high (Buck et 
al., 1976). NEL and seizure susceptibility are reversible 
by dietary rehabilitation. Audiogenic seizure susceptibi 1-
ity may remain high even though serum magnesium concentra-
tion is high (Buck et al., 1976). This is due to the low 
magnesium concentration in CSF. It is also concluded that 
hyperexcitabi lity relates to CSF rather than serum magnesium 
concentrations (Buck et al., 1978). Mahoney et al. (1983) 
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showed that fasting magnesium deficient rats overnight 
results in decreasing seizure susceptibility but does not 
affect latency. They also showed tnat hign-fat diets 
increase seizure incidence. 
Magnesium Deficiency: 
Calcium, Phosphorus, Sodium, 
and Potassium Relationships 
Magnesium deficient animals witn low phosphorus intake 
nave reduced seizure susceptibility (Bernhard, 1982). On 
the other hand, nigh dietary calcium concentration increases 
the severity of seizures in animals (Bronner and Coburn, 
1981; Chutkow, 1974; Colby and Frye, 195la, 195lb). 
The physiological functions of calcium include muscle 
contraction, bone growth, blood clotting, and nerve impulse 
transmission. Low calcium and magnesium concentrations in 
the CSF have been shown to cause hyperexcitability of the 
central nervous system (Grunes, 1979). 
Tetany, caused by magnesium deficiency, occurs in many 
species (Aikawa, 1981). The symptoms include opisthotonus, 
hyperexcitability, muscular twitching, and convulsion. It 
also has a relationship between calcium and magnesium. 
Tetany does not occur because of hypomagnesemia alone 
(Aikawa, 1981; Halpern, 1985b; Zimmet, 1968). It has been 
reported in association with low plasma calcium levels and 
with low concentration of magnesium in CSF. 
Phosphorus is one of the major anions in eel ls and is a 
component of the energy compound ATP which is essential to 
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all cell functions. It is associated with nerve activity, 
and muscle contraction (Tortora and Anagnostakos, 1984). 
Magnesium deficiency is found to cause hyperphosphatemia, 
hypomagnesemia and hypercalcemia (Bronner and Coburn, 1981). 
It is also associated with increased or unchanged sodium 
concentration in serum (Bronner and Coburn, 1981; Wacker, 
1980). Phosphorus depletion causes hypomagnesemia, hyper-
calcemia, and hypophosphatemia (Kreusser et al., 1978). 
Phosphorus increases the requirement of magnesium because 
phosphorus deficiency increases the excretion of magnesium 
and decreases serum magnesium concentration. High phospho-
rus intake is associated with hypocalcemia (Reddy et al., 
1973; Seelig, 1980). Bernhard (1982) showed that diets low 
in phosphorus reduce the incidence of magnesium deficient 
seizur e s, but diet that is low in both phosphorus and cal-
cium increases the seizures in magnesium deficient rats. 
The magnesium-potassium relationship is similar to the 
magnesium-calcium antagonism. High potassium in a magnesium 
deficient diet increases audiogenic seizure susceptibility 
(Chutkow, 1974; Colby and Frye, 195lb). Moreover, the 
combination of high calcium and high potassium diet is found 
to increase the severity of magnesium deficient syndromes. 
Serum potassium concentration in magnesium deficiency has 
been reported unchanged (Chutkow and Meyers, 1968). High 
potassium diet reduces plasma magnesium in animals (Mclean 
et al., 1985). It is believed that magnesium becomes 
1 1 
deposited into the tissues since urinary magnesium does not 
change (Duarte, 1980). Magnesium deficiency causes hypo-
kalemia (Rude and Singer, 1981). This may be due to the 
inhibition of (Na+-K+)~ATPase which is required for normal 
Na-K pump function (Whang, 1983). Magnesium is also 
required for potassium retention in the cells. Combination 
of magnesium and potassium deficient diet has been reported 
to prevent magnesium deficiency symptoms (Forbes, 1966). 
Chutkow (1974) reported that magnesium deficient rats 
fed high dietary sodium had increased severity of audiogenic 
seizures. 
The purposes of this research were to determine the 
effects of varying levels of calcium and phosphorus in mag-
nesium deficient diets on audiogenic seizure susceptibility 
and serum mineral concentrations of young rats. 
12 
MATERIALS AND METHODS 
Animal Care 
Male weanling Sprague-Dawley rats (Simmonsen Lab, Inc., 
Gilroy, California) were used throughout. They were accli-
mated to Purina animal chow at least 24 h before starting 
the experiments. They were housed individually in stainless 
steel cages with wire mesh fronts and bottoms. Diets and de-
ionized water were provided ad libitum. Animal room temper-
ature was kept between 23 and 28 °c. Lights were on auto-
matically from 0800 to 2000 h daily. Diets consisted of 20% 
casein, 58-63% dextrose, 5% fat (as corn oil), 2% vitamin 
mixture (Table 1), 5-10% mineral mixture (Tables 2 and 3) 
with or without magnesium, and 5% fiber (white wood cellu-
lose). Water bottles, feeding cups, cages and animal room 
were sanitized weekly. 
On the 17th day, animals were weighed, tested for sei-
zures, blood samples were collected via retro-ocular punc-
ture, and killed by decapitation. Audiogenic seizure was 
performed by placing the rats in a metal chamber which con-
tained two school emergency buzzers producing 115 dB for 90 
seconds or until tonus occurred as described by Buck et al. 
(1978). Seizure scores were rated on a scale of Oto 5. 
Zero signified no seizure; 1 = rapid running; 2 = clonic, 
characterized by ful 1 body convulsions but with the animal 
usually on its fe e t; 3 = tonic flexion, characterized by the 
animal on its side, rigid and kicking; 4 = tonic extension, 
13 
Table 1. Vitamin mixture composition. 
Vitamin Amount/kg mixture Amount/kg diet 
Alpha Tocopherol 5.00 g 110.00 mg 
L-Ascorbic acid 45.00 g 99.00 mg 
Choline chloride 75.00 g 1. 6 5 g 
0-Calcium pantothenate 3.00 g 66.00 mg 
i-Inositol 5.00 g 110.00 mg 
Mena di one 2. 2 5 g 49.50 mg 
Niacin 4.50 g 99.00 mg 
p-aminobenzoic acid 5.00 g 110.00 mg 
Pyridoxine-HCl 1. 00 g 22.00 mg 
Riboflavin 1. 00 g 22.00 mg 
Thiamine-HCl 1. 00 g 22.00 mg 
Biotin 20.00 mg 0.44 mg 
Fol i c acid 90.00 mg 1. 98 mg 
Vitamin B-12 1. 35 mg 0.03 mg 
* * Vitamin A acetate 900,000 i • u • 19,800 i • u • 
* * Calciferol-0 2 100,000 i • u • 2,200 i • u • 
Dextrose to 1, 0 0 0 g to 22 g 
* . l • u • = international units 
Table 2. Mineral pre-mixture. 
Mineral Amount/kg pre-mixture Amount/kg mineral mix 
ZnS0 4 .7H 20 1. 176 g 5.90 mg 
MnS04.H2U 3.420 g 17.30 mg 
CuS04 .5H 2o 0.442 g 2.20 mg 
Na2M04.2H20 0.012 g 0. 10 mg 
KI 0.004 g 0.02 mg 
CoCl 2 .6H 2o 0.004 g 0.02 mg 
Feso 4 .7H 20 3.500 g 175.00 mg 
Table 3. Magnesium deficient mineral mixture. 1 
Mineral Amount/kg mineral mixture Amount/kg diet 
CaC03 
( 2 ) 
( 3 ) 14.00 280.000 9(4) g 
420.000 g 42.00 g 
NaH2P04 
( 2 ) 
341.000 g (3) 17.05 g 
511.500 g ( 4) 51. 15 g 
Na2co3 205.000 g 
( 5 ) 10. 2 5 g 
KCl 76.300 g 3.82 g 
Mineral pre-mixture 8.558 g 427.90 mg 
Dextrose to 1000 g to 50 g 
(l)For normal diet, Mg was supplied by adding 
1.40 g MgCO /kg diet 
~2 )For low pho~phorus and/or calcium dietary level 
(~))For normal phosphorus and/or calcium dietary level 
( 5 )For high phosphorus and/or calcium dietary level For low phosphorus dietary level 
14 
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characterized by rigidity and extended legs; 5 = lethal sei-
zure. Due to the loud noise, testing had to be done in 
another room with all doors closed. Animals were placed in 
the testing chamber cage for a few seconds before starting 
the bel Is. 
Mineral Analyses 
Calcium (Ca) and magnesium (Mg) were analyzed by using 
an Instrumentat i on Laboratories 457 Atomic Absorption Spec-
trophotometer. One percent of 100,000 ppm lanthanum solu-
tion was added to minimize phosphate interferences. The 
solution was made by d i ssolving 234.40 g La2o3 in 440 ml HCl 
and diluted to 2 litres with deionized H2o. 
Phosphorus (P) analyses of all samples were performed 
by method 22.042 of the A.O.A.C. (19 80) using molybdovana-
da t e reagent and absorbance determined at 400 nm with a 
Bec kman DB-GT Grating Spectrophotometer. 
Potassium (K) and sodium (Na) were determined by emis-
sion spectroscopy using the Instrumentation Laboratories 457 
Atomic Absorption Spectrophotometer. 
diluted in demineralized H2o. 
Dietary and Serum Analyses 
The samples were 
Diets were analyzed by ashing 1.0-2.0 g of diet in por-
celain crucible for 48 hat 550° C. After cooling, 5 ml of 
6N HCl were added. The samples were slowly heated for 15 
min to completely solubilize the ash. They were then 
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diluted to 100 ml with demineralized H2o, and analyzed for 
magnesium, calcium, phosphorus, sodium and potassium ('Tables 
4 and 5). 
Blood samples were allowed to clot at room temperature 
for approximately 2 h. They were centrifuged at 2000 rpm for 
30 min. Serum was transferred to a new test tube by using 
Pasteur pipettes and kept refrigerated for approximately 20 
h before dilution for mineral analyses. 
The serum was di luted 1:100 by putting 0.1 ml serum in-
to a 10 ml volumetric flask and made to volume with deminer-
alized H2u. For magnesium analysis, 1 ml of the di luted 
serum was added to 0.1 ml of 100,000 ppm lanthanum solution 
in a 10 ml volumetric flask and made to volume with deminer-
This gave a final dilution of 1:1,000. For 
calcium analysis, the 1:100 dilution was made with 1% of 
100,000 ppm lanthanum solution. 
Phosphorus analysis was done by adding 1 ml of 30% tri-
chloroacetic acid to 5 ml of the diluted serum, stirring 
with vortex mixture, and allowing to stand at room tempera-
ture for 20 min (A.O.A.C, 1980; method 20.138e}. The sam-
ples were then centrifuged at 2,000 rpm for 10 min. One ml 
of molybdovanadate reagent was added to 4 ml of the super-
natant and al lowing the color to develop for 15 min. Opt i -
cal densities of the samples were determined at 400 nm. 
Sodium analysis was done by diluting the serum samples 
1:100 with demineralized H2o. Potassium was analysed by 
Table 4. Concentration of minerals in diets 
Experiment I.a 
Diet Mg Ca 
mg/g mg/g 
Mg-Ca=P= b 0.03+0.006c 6.61+1.18 
Mg-Ca=P- 0.03+0.001 7.64+0.19 
Mg-Ca-P= 0.05+0.0004 0.49+0.04 
Mg-Ca-P- 0.03+0.001 0.25+0.03 
aRequirements for normal growth (mg/g) Mg = 
Ca = 
p = 











= mean normal dietary level 
cMean+standard deviation 
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aRequirement for normal growth (mg/g): Mg= 0.04, Ca = 5.60, P = 4.40, 
Na = 0.60, K = 2.00 
b Analyzed values: - means deficent dietary level; 
= means normal dietary level; 
+ means high dietary level 
c Mean+standard deviation ...... 
o:i 
diluting the solution 1:10 with demineralized H2o. 
Statistical Analysis 
19 
Means and standard deviations were calculated. Chi-
square analysis was used to analyze the seizure incidence 
data at P<0.05. Analysis of variance {ANOVA) was performed 
for serum and body weight. For Experiment I, 2x2 factorial 
ANOVA was used to determine the effects of low calcium and 
low phosphorus dietary levels on serum mineral concentra-
tions of magnesium deficent rats. Least significant differ-
ence (LSlJ) values were computed for all statistically signi-
cant F ratios {0.95 or 0.99). A completely randomized de-
sign ANOVA was performed to determine the difference in 
serum mineral concentration among treatment diets in Experi-
ment I 1. A f a ctorial arrangement of treatments (3x3) was 
also used to s ee the e ffect of low, normal, and high dietary 
calcium and phosphorus levels with magnesium deficiency. 
Experiment I 
Animals were randomly assigned to one of these dietary 
groups; 1) magnesium deficient {Mg-Ca=P=), 2) magnesium de-
ficient, low phosphorus (Mg-Ca=P-), 3) magnesium deficient, 
low calcium (Mg-Ca-P=), and 4) magnesium deficient, low 
phosphorus-low calcium (Mg-Ca-P-). Rats were fed animal 
chow for 48 h prior to starting the experiment. Animals 
weighed between 75 and 93 g (84~4 g) with the majority 
weighing between 80 to 88 g on the first day of the experi -
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ment. They were tested for audiogenic seizure susceptibility 
on day 17. Testing was done across treatments to minimize 
any time and handling effects. Blood was collected approxi-
mately 5 min after the animal recovered from the seizure. 
The animal then was killed by decapitation. 
Experiment II 
Animals were randomly assigned to ten groups of 15 
rats. They were fed the following diets: 1) magnesium 
control (normal diet, Mg=Ca=P=), 2) magnesium deficient 
{Mg-Ca=P=), 3) magnesium deficient, low phosphorus {Mg-Ca= 
P-), 4) magnesium deficient, low calcium {Mg-Ca-P=), 5) 
magnesium deficient, low phosphorus-low calcium {Mg-Ca-P-), 
6) magnesium deficient, high phosphorus (Mg-Ca=P+), 7) 
magnesium deficient, high calcium (Mg-Ca+P=), 8) magnesium 
deficient, high phosphorus-low calcium {Mg-Ca-P+), 9) magne-
sium deficient, high calcium-low phosphorus (Mg-Ca+P-), and 
10) magnesium deficient, high phosphorus-high calcium 
(Mg-Ca+P+). They were given animal chow for 48 h before 
starting the experiment. On the first day of the experi-
ment, they weighed between 59 and 91 g (77~6 g). On day 17, 
ten rats in each dietary group were tested for audiogenic 
seizure susceptibility. The animals with the Mg=Ca=P= diet 
were not tested for seizures because of their lack of 
susceptibility (Bernhard, 1982; Buck, 1978, Mahoney, 
unpublished observations). Testing, blood samples, and 
dilutions of serum were done as described for Experiment I. 
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RESULTS AND OISCUSSION 
The symptoms of magnesium deficiency, vasodilation and 
edema of the ears, nose and claws, and hyperexcitabi lity, 
occurred as expected (Kruse et al., 1932). No such symptoms 
were observed in animals fed with the normal diet. Edema 
and redness of the extremities were very severe on the 5th 
and 6th day, and then reduced. Animals had very low appe-
tites and grew poorly. Each day, animals wasted half or more 
of their food by digging out and/or overturning of the feed-
ing cups. This did not happen in animals fed control diet. 
To minimize this behavior, the anti-digging rings were used 
and animals were fed everyday. 
Skin lesions were seen on almost all magnesium defi-
c i ent animals even those that did not show redness and edema 
of the ears, nose and claws. Animals in Experiments I and 
II fed the Mg-Ca=P=, Mg-Ca=P-, Mg-Ca-P=, Mg-Ca-P-, Mg-Ca=P+, 
Mg-Ca+P= and Mg-Ca+P+ diets all had the classic magnesium 
deficiency symptoms whi ch did not occur in animals fed 
Mg-Ca-P+, and Mg-Ca+P- diets. These latter animals also had 
significantly decreased incidence of seizures (Table 6). 
The results of the seizure testing, and weight gains 
are found in Table 6. Weight gain did not relate to the 
percent of audiogenic seizure susceptibility. It depended 
on dietary treatment (P<0.05). Seizure susceptibility was 
also dependent on treatment diets (overal 1 Chi-square; 11.35 
and 21.67, P<0.01, for Expts I and II, respectively). 
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Table 6. Summary of weight gain and percent seizure as 
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Serum analyses for Experiments I and II can be found in 
Tables 7-10. The data in Table 9 were calculated from all 
animals in Experiment II but only serum data from animals 
tested for audiogenic seizure susceptibility were reported 
in Table 10 (Appendix A; Table 12). 
Higher serum magnesium, calcium, and phosphorus concen-
trations were observed in Experiment I than Experiment II. 
This might be because of the leakage of magnesium from the 
erythrocyte due to hemolysis in Experiment I. 
Magnesium Deficient Diet (Mg-Ca=P=) 
This diet served as the magnesium deficient control. In 
both experiments, these animals had classic symptoms of mag-
nesium deficiency; vasodi lation, and edema of the ears, nose 
and claws, as expected (Kruse et al., 1932). They also had 
100% seizure incidence (Table 6) which is higher than pre-
vious studies in this laboratory (Bernhard, 1982; Buck, 
1978; Mahoney, unpublished observations). This might be due 
to variations in the composition of diets (magnesium and fat 
contents) and in animal handling among these studies. 
Serum magnesium was decreased by this treatment (Tables 
9 & 11; Appendix A). Serum calcium and phosphorus concen-
trations were inversely related to serum magnesium (Mg=Ca=P= 
vs. Mg-Ca=P=). This confirms that magnesium deficient diet 
causes hypomagnesemia, hyperphosphatemia, and hypercalcemia 
(Bronner and Coburn, 1981; Rude and Singer, 1981). Serum 
potassium and sodium were elevated only slightly (Tables 9 & 
Table 7. Serum Mg, Ca, and p concentrations. 
Experiment I.a 
Mg a p 
l) i et (mg/dl) , (mg/dl) (mg/dl) 
Mg-Ca=P= 1.76+0.62 17.3+2.l 12.5+2.2 
Mg-Ca=P- 1.22+0.49 12.1+4.0 8. 3+3. 2 
Mg-Ca-P= 1.49+0.61 8.4+2.9 11.4+2.7 
Mg-Ca-P- 1.80+0.47 14.9+2.6 10.0+3.0 
LSD{.05/.01) 0.42/0.56 2.3/3.1 2.1/2.82 
Table 8. Comparison of serum minerals based on seizure 
occurrence. Experiment I.a 
Mg Ca P 
(mg/dl) (mg/dl) (mg/dl) 
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Seized Not Seized Seized Not Seized Seized Not Seized 
Mg- 1. 7 6 1 7. 3 12. 5 
Ca=P= +0.62 + 2. 1 + 2. 2 
Mg- 1. 39 0.69 13.4 9.0 10.0 4. 1 
Ca=P- +0.39 +0.23 +4.0 +2.0 + 1. 8 + 1. 6 
Mg- 1. 84 1. 29 10.0 7. 5 13. 2 11. 0 
Ca-P= +0.30 +0.66 +2.8 +2.8 + 2. 1 + 2. 7 2 
Mg- 1. 86 1. 4 5 15. 5 13. 2 10.4 8.6 
Ca-P- +0.47 +0.27 +2.8 +0.3 +3.2 + 1. 0 
a Mean+standard deviation 













































































abcdef Mean+standard deviation for 15 animals (normal group n = 11). 
Values with-the same superscript within the column are not significantly 
different (P<0.01). Mean differences must equal or exceed the Least 
Significant Difference value to be statistically significant at the 
indicated levels of probability. 
N 
(,}'1 
Table 1 0. Comparison of serum minerals based on seizure occurrence. 
Mg Ca p K Na 
Diet Seized Not Seized Not Seized Not Seized Not Seized Not 
Seized Seized Seized Seized Seized 
Mg-Ca=P= 1. 11 - 1 U. 1 - 11. 9 - 40.9 - 268 
+0.23 + 1 . 0 +2.3 + 6. 7 +18 - - -
Mg-Ca=P- 1. 49 1. 11 11. 4 11. 0 10.8 5. 3 37.8 28. 1 27 1 244 
+0.34 +0.52 + 1. 0 + 1. 3 + 1. 3 +0.7 +4.7 +3.4 +26 +39 - - - -- - -
Mg-Ca-P= 1. 40 0.98 8.0 7 • 1 10.0 6. 5 29.6 23.8 275 272 
+0.43 + 0. 14 + 1. 3 +0.6 + 3. 1 +O. 7 +4.3 + 2. 1 +26 ... 21 - - - - - - - -
Mg-Ca-P- 1. 44 1. 0 7 8.8 7 • 4 1 0. 5 6. 5 31. 7 26.2 261 272 
+0.24 +0.10 + 1. 0 + 0. 1 + 3. 7 +0.9 +8.4 +2.2 +23 +13 - - - - - - - -
Mg-Ca=P+ 1. 5 2 1. 26 7 • 1 4. 1 2 3. 3 18. 5 25.8 21. 2 270 263 
+0.15 + 0. 11 +2.8 +0.7 + 10. 7 +4.6 + 1 1 • 7 +6.4 +42 +19 - - - - -
Mg-Ca+P= 1. 4 7 - 10. 1 - 14.6 - 39.8 - 246 
+0.24 +2.2 + 4. 5 +7.6 +19 - - - - -
Mg-Ca-P+ - 1. 66 - 6. 2 - 9. 5 - 20.3 - 240 
+0.23 + 0. 7 + 1. 8 + 2. 1 +20 - - -
Mg-Ca+P- - 1. 20 - 8. 5 - 5 • 7 - 31. 4 - 238 
+ 0. 15 +0.6 - + 1. 0 + 3. 7 +25 - -
Mg-Ca+P+ 1. 4 7 1. 00 l O. 0 4. 6 l 7 • 0 18. 1 4 2. 5 3 2. 7 281 331 
+0.23 ( * ) + l . 7 ( * ) +2.9 ( * ) +5.0 ( *) +21 ( * ) - -
a Mean+standard deviation for tested animals, mg/dl. Experiment I I. 
( * ) n=T N 
°' 
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Table 11. Comparison of serum mineral concentrations with 
































means that the magnesium deficient animals 
(lower) serum mineral concentrations (LSD, 
means not statistically significant. 














Table 12. Within group comparison of serum mineral 
concentrationsa. (Experiment II} 
Diet Mg 







































































a + means that magnesium deficient animals that seized or 
were tested for seizure had higher serum mineral 
concentrations (P<0.05). N means not statistically 
significant. Total observations, n = 10 and 15 for 
seizure and testing, respectively. 
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11; Appendix A) due to this diet. 
To determine if seizure affected serum mineral concen-
trations, the mineral values for those that convulsed were 
compared with those that did not (Tables 8, 10 & 12). It 
was found that those rats that convulsed had higher serum 
potassium and sodium than those which did not. The serum 
mineral values of the animals tested for seizure suscepti-
bi lity were higher in magnesium, calcium and sodium compared 
with untested rats (Table 12). This might be due to the 
mobilization of minerals from bone after a convulsion 
(Martindale and Heaton, 1964). 
Magnesium Deficient-
Low Phosphorus (Mg-Ca=P-) 
Low phosphorus in magnesium deficient diet caused a 
significant reduction in seizure susceptibility in Experi-
ment I but not in Experiment II (Table 6). In both experi -
ments, animals fed this diet also had the classical physical 
appearance of magnesium deficiency. Although seizure inci-
dence and score (severity) were reduced in Experiment I, 
they were not significantly affected in Experiment II. 
Serum magnesium was decreased in the animals fed this 
diet (Tables 7, 9 & 11). Phosphorus depletion in magnesium 
deficiency caused hypercalcemia in both experiments. This 
confirms the finding of Kreusser et al. (1978) and Parker 
(1985). Serum potassium and sodium did not change compared 
with control (Mg=Ca=P=; Table 11). 
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Serum magnesium, calcium and phosphorus were higher in 
animals that convulsed in Experiment I than those that did 
not {P<0.05, Table 8). In Experiment II, seizure susceptible 
animals had increased {P<0.05} serum phosphorus and potas-
sium (Table 12}. This supports the idea that variations in 
serum minerals affect seizure susceptibility of magnesium 
deficient rats. However, since the blood was drawn after 
seizure testing, it is possible that these changes in serum 
mineral levels are due to the effects of seizures. 
Magnesium Oeficient-
Low Calc1um (Mg-Ca-P=) 
Animals fed the low calcium diet had reduced physical 
symptoms of magnesium deficiency in both experiments. This 
confirms the observations of Bernhard (1982) and Forbes 
(196 3 ). These animals also gained more wei ght than those 
fed the Mg-Ca=P= or Mg-Ca=P- diets (Table 6). 
Low dietary calcium reduced audiogenic seizure suscep-
tibility {Table 6~ 38% and 30% seizure for Expts I & II). 
The severity of the seizures that did occur were also 
reduced and the latencies were increased by this diet in 
both experiments compared with magnesium deficient control 
{Mg-Ca=P=). Bernhard (1982) observed that this diet reduced 
seizure incidence only slightly (53%). Mahoney (unpublished 
observation) observed in higher percent seizure (80%) than 
was found in this study. This might be due to higher dietary 
fat content (10% in his experiment vs. 5% this study} and in 
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the concentrations of sodium (11.17 vs. 3.37 mg/g) since 
both high fat diet (Mahoney et al., 1983) and high sodium 
(Chutkow, 1972} increases the severity of audiogenic seizure 
susceptibility. 
Low dietary calcium did not affect serum calcium but it 
seemed to decrease phosphorus (Expt I; Table 7) and potas-
sium (Expt II; Table 9), and increase serum sodium (Expt II; 
Table 9) in compared with magnesium deficient control (Mg-
Ca=P=). Compared with control (Mg=Ca=P=), serum magnesium 
and potassium were decreased, and sodium was increased. 
Audiogenic seizure susceptible rats fed this diet had 
increased serum magnesium, phosphorus (P<0.05; Expts I & II; 
Tables 8 & 10) and potassium (P<0.05; Expt II; Tables 10 & 
12) compared with those that did not convulse. 
Magnesium Deficient-
Low Phosphorus-Low Calcium 
(Mg-Ca-P-) 
Reduction of audiogenic seizure susceptibility was seen 
in magnesium deficient rats fed diet low in both calcium and 
phosphorus (50%) and latency was increased for Experiment II 
only. However, the severity of the seizures was reduced in 
both experiments. 8ernhard (1982) and Mahoney (unpublished 
observation) observed higher percent seizure than this study 
with 86% and 82%. This might be due to differences in the 
higher dietary magnesium and fat contents in their experi-
ments and possible differences in animal handling techniques 
between this study and their studies. This study was higher 
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in magnesium than Bernhard's (1982) but lower in fat content 
in diet than Mahoney's (unpublished observation). 
Comparing to Mg-Ca=P=, serum calcium and phosphorus 
values were decreased in the animals fed Mg-Ca-P- diet in 
both experiments {Tables 7 & 9). Serum potassium and sodium 
remained unchanged (Expt II; Table 9). 
Animals that convulsed had higher (P<0.05) serum magne-
sium, calcium and phosphorus in both experiments. Serum po-
tassium and sodium were not affected (Expt II; Table 12). 
Ma~nesium Oeficient-
Hi h Phosphorus (Mg-Ca=P+) 
Animals fed magnesium deficient-high phosphorus diet 
were observed to be very hyperexcitable and were very ag-
gressive. They also consumed diet and gained weight the 
l e ast (Table 6). This diet also ameliorated physical symp-
toms of magnesium deficiency including reduced seizure sus-
ceptibi lity and seizure severity. This seizure incidence 
was much lower than was previously observed by Mahoney 
(unpublished observations; 89% and 80%). This might be due 
to an effect of higher dietary fat in his study which in-
creases seizure susceptibility in magnesium deficient rats 
(Mahoney et al., 1983). It is possible that the animals fed 
this diet may have been semi -fasted during this experiment 
since they had the least weight gain. Fasting also decreases 
seizure susceptibility in magnesium deficient rats (Mahoney 
et al., 1983). 
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That high dietary phosphorus level causes hypocalcemia 
was confirmed in this study (Table 9; Reddy et al., 1973; 
Seelig, 1980). High dietary phosphorus increased the serum 
phosphorus (Tables 9 &' 11) and decreased (P<U.01) the serum 
magnesium and potassium concentrations in this study. 
The seizure susceptible rats had increased serum magne-
sium and calcium (P<0.05) compared with the rats that did 
not convulse (Tables 10 & 12). The convulsions of the ani-
mals fed this diet might be due to both hypomagnesemia and 
hypocalcemia (Zimmet, 1968). High magnesium and calcium in 
serum might be due to release of minerals from bone 
(Martindale and Heaton, 1964). 
Ma~nesium Oeficient-
Hi h Calcium (Mg-Ca+P =) 
High calcium, low magnesium di e t resulted in 100% audi-
ogenic seizure susceptibility as expected (Colby and Frye, 
l95la, 195lb) with the highest in the average seizure sever-
ity score among the tested groups (4.1; Table 6). Some ani -
mals (6/14 rats) fed this diet also convulsed spontaneously 
during testing animals in other groups. Spontaneous sei -
zures were not seen in the other groups except for the 
Mg-Ca+P+ diet. One animal died before testing day. 
This diet resulted in increased serum magnesium but did 
not significantly affect serum calcium, phosphorus, potas-
sium nor sodium levels compared with the Mg-Ca=P= diet 
(Table 9). This was surprising because seizure susceptibi 1-
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ity was high even though serum magnesium was elevated 
(P<0.01). Seizure testing appeared to increase (P<0.05) 
serum magnesium compared with non-tested animals 
A; Tables 10 & 12). 
Magnesium Deficient-
Hi§h Phosphorus-Low Calcium 
(M -Ca-P+) 
(Appendix 
The physical symptoms of magnesium deficiency were re-
duced in this treatment. However, skin lesions were seen on 
some animals in this group. Also, it totally prevented sei-
zures (Table 6). 
Serum magnesium increased to normal levels (Tables 9 & 
11). It is interesting that serum magnesium was normal even 
though this diet was clearly magnesium deficient (Table 5). 
Serum calcium and potassium levels were decreased while se-
rum phosphorus and sodium remained unchanged. It is possi-
ble that bone minerals were being mobilized causing elevated 
serum magnesium level in this diet. However, this did not 
occur in the Mg-Ca-P= and Mg-Ca-P- treatments. The return 
of serum magnesium to normal could account for the prevent-
i o n of seizures in this dietary treatment. 
Audiogenic seizure testing did not affect serum mineral 
concentrations in this diet treatment (Table 12). 
Magnesium Deficient-
Hl §h Calcium-Low Phosphorus 
(M -Ca+P-) 
The physical symptoms of magnesium deficiency did not 
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occur in this diet treatment. Animals in this group were 
observed to be aggressive but less than Mg-Ca=P= and 
Mg-Ca=P+ groups. They also behaved such that approximately 
1/3 of their food eacn day was made into small balls. To 
minimize this behavior, their feeding cups and cages were 
sanitized more often than other groups. Audiogenic seizures 
were totally prevented in this experimental group (Table 6) 
even though serum magnesium levels were low (Tables 9, 10 & 
11). This diet caused very low serum phosphorus, reduced 
serum potassium and left serum sodium levels unchanged. 
Audiogenic seizure testing did not affect serum mineral 
concentrations in this diet treatment (Table 12). 
Magnesium Ueficient-
R1§h Calc1um-R1gh Phosphorus 
(M -Ca+P+} 
Animals fed this diet had classic symptoms of magnesium 
deficiency. They were also very aggressive. Chutkow (1972) 
found that magnesium deficient diets which were also high in 
calcium and sodium cause increased severity of audiogenic 
seizures. That observation was confirmed in this study with 
three of 15 animals dying during seizure testing. Une of 9 
animals tested did not convulse in this diet (Table 6). 
Serum calcium was similar to normal rats (Mg=Ca=P=) but 
was decreased compared with the Mg-Ca=P= diet group (Table 
9). This might be the effect of high phosphorus intake which 
causes hyperphosphatemia and hypocalcemia (Reddy et al., 
1973; Seelig, 1980}. Serum phosphorus was increased but 
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serum potassium concentrations remained unchanged compared 
with Mg-Ca=P= {Tables 9 & 11). 
Seizure testing was associated with higher magnesium 
and calcium concentrations in serum compared with non-tested 
animals in this diet group (P<0.05; Appendix A; Table 12). 
Effect of Dietary Calcium and 
Phosphorus Levels on 
Serum Minerals Concentrations 
Serum magnesium concentration was decreased by all mag-
nesium deficient diets e xcept for the Mg-Ca-P+ diet (Table 
9). Serum magnesium concentration tended to be increased 
with high dietary phosphorus level s but it was not changed 
by dietary calcium levels. 
Serum calcium and pnosphorus increased in magnesium de-
f iciency (Mg=Ca=P= vs. a ll magne sium deficient diets). Se-
rum calcium concentration di d not consistently increase with 
increasing dietary calcium intake. Serum phosphorus was 
also related to dietary pnospnorus levels. 
Serum sodium increased a s a result of magnesium defi-
ciency in four diets (Tables 9 & 11). But these changes 
were not related to seizure susceptibility (Table 6). 
zure testing did not affect serum sodium (Table 12). 
Se i -
Serum potassium was significantly decreased in the Mg-
Ca-P-, Mg-Ca=P+ and Mg-Ca-P = diets but these changes were 
not related to seizure susceptibility. As was the case for 
magnesium, calcium and phosphorus, serum potassium level was 
generally increased in rats tnat convulsed compared with 
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those that did not. This effect was strongest for rats fed 
the Mg-Ca=P- diet (Tables 8 & 12). 
PART II 
EFFECT OF CALCIUM AND PHOSPHORUS ON HRAIN MONOAMINES 




Many studies (i.e. Kohsaka et al., 1978; McNamara, 
1984; Poenaru et al., l984; Pycock et al.,1978) revealed the 
relationship between neurotransmitters abnormalities and 
seizure susceptibility. Several neurotransmitters are 
implicated in those behavioral defects. Catecholamines are 
a group of neurotransmitters which are derived from the 
amino acids phenylalanine and tyrosine. Their physiological 
functions include increasing and decreasing of blood 
pressure, excitation of the nervous system, and increasing 
of the cardiac output (Gorbman et al., 1983; Kutsky, 1981). 
Catecholamines, norepinephrine (NE), epinephrine (EP), 
and dopamine (DA), increase serum magnesium in rats (8ronner 
and Coburn, 1981; Wallach, 1980). Norepinephrine also 
increases (Na+-K+)-ATPase activity in the brain (Yoshimura, 
1973). In contrast, Logan and O'Donovan (1976) reported 
that norepinephrine has no effect on the activity of the 
enzyme. Catecholamines are secreted and stored in the 
adrenal medulla. The retention of these amines in adrenal 
medulla requires ATP, magnesium ion, and ATPase (Chutkow, 
1980; Gorbman et al., 1983). The release of catecholamines 
requires calcium ion (Agranoff, 1975; Gorbman et al., 1983; 
Kutsky, 1981; Wallach, 1980; Woodbury, 1984) but magnesium 
inhibits this function (Wacker, 1980). They are, especially 
norepinephrine, involved i n seizure susceptibi I ity. 
Norepinephrine depletion increases seizure susceptibility in 
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animals (Burley and Ferrendelli, 1984; Killam and Killam, 
1984; Laird et al., 1984; Mason and Corcoran, 
Woodbury, 1984). 
1979; 
Dopamine causes hyperexcitabi lity in animals (Pycock et 
al., 1978). It also affects feeding and drinking behavior 
of adult rats (~runo et al., 1984). A high concentration of 
dopamine is found in the basal ganglia of the brain. It i s 
a precursor for norepinephrine. It is important in the con-
vulsive seizure mechanism (Kohsaka et al., 1978). Dopamine 
also increases (Na+-K+}-ATPase activity (Yoshimura, 1973). 
Poenaru et al. (1984) have shown that the dopamine concen-
trations in the brain increases in magnesium deficient rats. 
To the contrary, some studies (Johnson et al., 1979; Laird 
et al., 1984} have been shown that the dopamine concentra-
tion is low in seizure susceptible animals. Brain dopamine 
concentration is decreased in magnesium deficient rats 
(Chutkow, 1980). Buck et al. (1978} found that cerebral 
intraventricular injection of I-dopa decreases nonspecific 
excitability level (NEL} in magnesium deficient rats. 
Serotonin (5-hydroxytryptamine}, one of the monoamines 
of the brain, is also associated with seizure susceptibility 
and hyperexcitability (Pycock et al., 1978). It is formed 
from the amino acid tryptophan. The concentration of tryp-
tophan is a limiting factor for serotonin formation (Curzon 
and Marsden, 1975; Denizeau and Sourkes, 1977; Garry, 1981). 
The storage of tryptophan in the hypothalamus decreases 
after raphe nuclei lesions (Denizeau and 
Maurizi (1985} suggested that tryptophan 
Sourkes, 
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supplementation 
might prevent seizures even though the dietary manipulation 
of tryptophan does not alter serotonin function in the brain 
(Trulson, 1985). Although serotonin receptors are found in 
almost every area of the brain (Haigler and Aghajanian, 
1977), this amine and its related enzymes are concentrated 
in the raphe nuclei of the midbrain and diencephalon (Gallup 
et al., 1977; Racine and Coscina, 1978; Saavedra, 1977). 
Unlike norepinephrine, the release of serotonin is not 
calcium dependent (Levine, 1972). The uptake of serotonin 
is not affected by dopamine nor norepinephrine. Decreasing 
and/or inhibition of serotonin synthesis increases seizure 
susceptibility (Browning, 1985; Johnson et al., 1979; Laird 
et al., 1984). Buck (1978) indicated that serotonin concen-
tration is higher in the brain of magnesium deficient rats 
compared with normal animals. On the other hand, Chutkow 
(1980) found that there is no change in brain but an 
increase in blood serotonin concentrations in magnesium 
deficiency. Serotonin is involved in ATPase activation in 
the brain (Yoshimura, 1973). It causes an increase in the 
activity of (Na+-K+)-ATPase in cerebral cortex. Essman 
(1980) reported that hypomagnesemia and hyposerotonemia are 
reversible by lithium carbonate (Li 2cu3 ) treatment. 
The purpose of this study was to determine the effects 
of magnesium deficiency and the effects of varying dietary 
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levels of calcium and phosphorus in magnesium deficient 
diets on brain neurotransmitter concentrations. 
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METHOD 
Rats, treated as previously described in Experiment 11, 
Part I, were decapitat~d after testing for audiogenic sei-
zure susceptibility between 1400 and 1800 h. Nine rats from 
each treatment diet were selected. They were chosen from 
the gtoups which were tested and killed in the same period 
of time. Brain parts (Figure l); cerebral cortex (A), 
midbrain (B), cerebellum (C), and medulla oblongata and pons 
(0), were dissected on ice and were placed separately in 
pre-weighed test tubes containing 0.05 M perchloric acid 
with 0.1% cysteine as an antioxidant (to prevent DOPAC loses 
at room temperature). The dissection of brain was done by 
the method of Glowinski and Iversen (1966). After weighing, 
they were kept at -7o0 c until the analyses were made. The 
weights of the brain parts were obtained by determining the 
gain in weight of the pre-weighed test tubes plus solution. 
Brain weights were determined as the sum of the weights of 
the brain parts for each rat. 
Each part of the brain was homogenized and centrifuged 
at 10,000 rpm, 4°C for 20-30 min. The supernatant was fil-
tered into a microcentrifuge tube (American Scientific 
Product) with Bioanalytical Systems MF-1 filters (0.2 micron 
pore size) by centrifugation at 2,000 rpm, 4°c for 2-5 
The supernatant was removed and stored in Eppendorf 
propylene tubes at -7o0 c. Norepinephrine 
3,4-dinydroxyphenylacetic acid (DOPAC), dopamine (OA), 
min. 
poly-
( NE ) , 
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Figure 1. Dissection diagram of rat brain. Thickened lines 
indicate positions of sections. 
A. 1) Cerebral cortex 
2) Hippocampus 
B. 3) Midbrain 
4) Hyp0thalamus 
C. 5) Cerebellum 
D. 6) Medulla oblongata and pons 
45 
5-hydroxy-indole acetic acid (5-HIAA), homovani l lie acid 
(HVA) and 5-hydroxytryptamine (5-HT) were analyzed using the 
high performace liquid chromatography {HPLC) method of Mayer 
and Shoup (1983). Al 1 ·chemicals used were HPLC grade. The 
mobile phase consisted of 28.3 g monochloroacetic acid, 9.35 
g of sodium hydroxide, 400 mg of sodium octyl sulfate, and 
0.5 g of Na2EDTA. Al 1 Chemicals were dissolved in 2 litres 
of distilled water, and filtered through 0.2 micron filtered 
paper. Tetrahydrofuran (THF) was added and the solution was 
capped to prevent THF evaporation. Twenty microlitres of 
sample were injected to the HPLC column (Bioanalytical 
System Model LC-150). The neurotransmitters were 
quantitated with an electrochemical detector (Bioanalytical 
System Model LC-3A with temperature controller Model LC-22A) 
using the amperometric method and a Hewlett Packard- 33 90A 
integrator. Elution time was approximately 20 min. 
Statistical Analysis 
Means and standard deviations were calculated for each 
part of the brain. Analyses of variance (ANOVA) were per-
formed. Complete randomized design ANOVA was computed to 
identify statistically significant difference between normal 
(Mg=Ca=P=) and each of the other diet treatments, and 
between animals that did and did not convulse for each part 
and each amine. A 3x3 factorial ANOVA was used to determine 
the effect of varying dietary levels of calcium and phospho-
rus on brain neurotransmitters. 
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RESULTS AND DISCUSSION 
Summaries of brain neurotransmitter concentrations in 
cerebral cortex, midbrijin, cerebellum, and medulla oblongata 
and pons are found in Tables 13 to 16, respectively. Magne-
sium deficient diets seemed to increase brain neurotransmit-
ters although statistically significant treatment effects 
were not shown in all parts and with all brain monoamines. 
NE, DA, and HVA were not significantly affected by magnesium 
deficiency {Mg=Ca=P= vs. all magnesium deficient diets) in 
any parts of the brain (one-way ANOVA; P<0.05; Table 17). 
Similarly, brain NE remained 
cient dog {Barbeau et al., 
1978) . 
normal in the magnesium defi-
1972) and rats {Buck et al., 
Animals which were fed with the Mg-Ca-P+ diet had 
normal concentrations of all neurotransmitters (Table 17). 
Animals fed this diet are interesting because they also had 
normal serum magnesium concentrations (Table 9; Part I). 
None of the magnesium deficient diets significantly af-
fected the midbrain neurotransmitters (Tables 14 & 17) even 
though the averages are somewhat higher than in control ani-
mals (Mg=Ca=P=). This confirms the result of Barbeau et al. 
{1972) in the dog that NE, HVA, and 5-HT are unchanged in 
midbrain. Failure to achieve statistical significance was 
due to high variation of the amines in the brain parts. 
Cerebral cortex content of DOPAC, 5-HT, and 5-HIAA 
(Tables 13 & 17) was significantly (P<0.05) elevated in the 
























DA DO PAC HVA 5-HT 5-HIAA % seizure 
715+41 67+6a 60+14 270+28a 169+26a 
745+62 85+10ab 55+10 319+44b 216+10bc 100 
731+53 89+15bcd 55+17 329+33bd 212+27bde 80 
730+57 107+47d 63+11 319+35b 206+3obf 30 
760+53 89+14bcd 60+12 326+20bd 206+26bf 50 
777+28 84+15ace 57+14 328+49be 214+33bg 30 
790+52 87+12bef 52+15 362+45cde 234+44ceg 100 
745+61 82+10acf 61+9 306+39ab 183+16af o 
747+57 81+13acf 66+13 310+49b 186+26adf O 
762+31 80+29acf 64+13 349+26bc 203+170bf 89 
NS 19/25 NS 40/53 28/38 
abcdefg Mean+standard deviation for 9 samples. Values with the same 
superscript within the column are not significantly different (P<0.05). 
Mean differences must equal or exceed the Least Significant Difference (LSD) 
value to be statistically significant at the indicated levels of 
probability. 
~ ......., 
Table 14. Summary of brain neurotransmitters. Midbrain (ng/g). a 
Diet NE DA 
Mg=Ca=P= 879+197 237+59 - -
Mg-Ca=P= 1040+317 283+68 - -
Mg-Ca=P- 1139+350 279+96 - -
Mg-Ca-P= 1023+441 317+114 - -
Mg-Ca-P- 1012+273 282+63 - -
Mg-Ca=P+ 1148+387 283+83 - -
Mg-Ca+P= 1075+289 274+67 - -
Mg-Ca-P+ 905+144 254+40 - -
Mg-Ca+P- 1041+256 262+49 - -
Mg-Ca+P+ 1242+218 300+65 
a Mean+standard deviation. 
values-were found. 
DO PAC HVA 5-HT 5-HIAA 
61+34 74+20 629+387 451+148 - - - -
73+21 74+35 637+212 653+242 - - - -
74+33 74+26 722+443 631+392 - - - -
78+36 98+67 652+151 571+174 - - - -
62+29 107+59 450+200 472+117 - - - -
72+29 90+35 692+466 554+210 - - - -
69+27 82+59 640+267 652+289 - - - -
76+16 90+43 498+163 485+132 - - -
51+12 110+62 685+199 543+213 - - - -
72+29 63+15 734+317 638+246 
No statistically significant treatment 'F' 
+:> 
ex:, 
Table 15. Summary of brain neurotransmitters. Cerebellum (ng/g). 
Diet NE DA 
Mg=Ca=P= 239+92 19+11 
Mg-Ca=P= 203+36 19+ 3 
Mg-Ca=P- 197+38 15+ 6 
Mg-Ca-P= 225+56 27+16 
Mg-Ca-P- 212+65 20+ 1 
Mg-Ca=P+ 199+55 16+16 
Mg-Ca+P= 179+34 10+13 
Mg-Ca-P+ 218+28 13+ 9 
Mg-Ca+P- 240+76 27+23 
Mg-Ca+P+ 198+33 12+ 4 





































abc Means+standard deviation for 
superscript within the column 
Mean differences must equal or 
(LSD) value to be statistically 
probability. 
9 samples. Values with 
are not significant different 
exceed the Least Significant 























































DO PAC HVA 
17+ 9 43+30 
28+ 6 61+44 
26+ 8 53+27 
28+16 49+19 

















506+ 95 bc 
444+ 74 ab 
482+56b 
475+119b 







506+1 40 bc 
109/144 
abcdefgh Mean+standard deviation for 9 samples. Values with the same 
superscript wTthin the column are not significantly different (P<0.05). 
Mean differences must equal or exceed the Least Significant Difference (LSD) 




Table 1 7 • Comparison of bra i n neurotansmitter concentrations with magnesium 
control (Mg=Ca=P=). 
NE DA DO PAC HVA 5-HT 5-HIAA 
O i et A B c D A B c D A B c D A B c D A B c D A B c D 
Mg-Ca=P= N N N N N N N N N N N N N N N N + N + + + N N + 
Mg-Ca=P- N N N N N N N N + N N N N N N N + N + + + N N + 
Mg-Ca-P= N N N N N N N N + N N N N N N N + N N N + N N N 
Mg-Ca-P- N N N N N N N N + N N N N N N N + N N + + N N + 
Mg-Ca=P+ N N N N N N N N N N N N N N N N + N N N + N N + 
Mg-Ca+P= N N N N N N N N + N N N N N N N + N + + + N N + 
Mg-Ca-P+ N N N N N N N N N N N N N N N N N N N N N N N N 
Mg-Ca+P- N N N N N N N N N N N N N N N N + N N + N N N N 
Mg-Ca+P+ N N N N N N N N N N N N N N N N + N + N + N N + 
A = Cerebr?l cortex, B = Midbrain, c = Cerebellum, D = Medulla oblongata and pons 
a+ means that the magnesium deficient animals had higher neurotransmitter (LSD, 




magnesium deficient rats compared with the control (Mg=Ca=P= 
vs. all magnesium deficient diets). Similarly, 5-HT was 
s i gnificantly elevated (P<0.05) in cerebellum, and medulla 
oblongata and pons (Tables 15, 16 & 17). Magnesium defi-
cient diets also increased 5-HIAA concentrations (P<0.05) in 
the medulla oblongata and pons (Tables 16 & 17). It is 
interesting that 5-HT i ncreased in all magnesium deficient 
animals except for the Mg-Ca-P+ diet (Table 17). This is 
probably due to the normal serum magnesium concentration 
observed in this diet group (Table 9; Part II). 
Audiogenical ly induced seizures had little or no affect 
on neurotransmitters in magnesium deficient rats (Table 18). 
NE was reduced (P<0.05) in the cerebral cortex in animals 
that had convulsed (Table 18, overal 1 ). However, the 
Mg-Ca-P = diet increased (P<0.05) NE concentrations in the 
midbrain, - and medulla oblongata and pons (Table 18). 
DA was increased (P< 0 .05) in medulla oblongata and pons 
(Table 18; Mg-Ca-P= and overall) of the animals that 
convulsed. 
Even though DOPAC (metabolite of DA) concentrations 
were not significantly different between animals that con-
vulsed and those that did not (Table 18, overall), its con-
centration was slightly increased in the brain except in 
midbrain. DOPAC concentrations were increased in the medulla 
oblongata and pons of animals that convulsed and were fed 
the Mg-Ca=P- and Mg-Ca-P= diets (Table 18). 
Table 18. Within group comparison of brain neMrotransmitter concentrations of animals that seized vs. those that did not. 
NE DA DO PAC HVA 5-HT 5-HIAA 
Diet A l3 c D A B c D A B c D A B c l) A B c D A B c D 
Mg-Ca=P- N N N N N N N N N N N + N N N N N N N N N N N N 
Mg-Ca-P= + N N + N N N + N N N N + - N N N N N N N N N N 
Mg-Ca-P- N N N N N N N N N N N + N N N N N N N N N N N N 
Mg-Ca=P+ N N N N N N N N N N N N N N N N N N N N N N N N 
1'19-Ca+P+ N N N N N N N N N N N N N N N N N N N N N N N N 
Overall - N N N N N N + N N N N N N N N N N + + + N N + 
A = Cerebral cortex, B = Midbrain, c = Cerebellum, 0 = Medulla oblongata and pons 




HVA, another DA metabolite, was slightly decreased in 
cerebral cortex, midbrain and cerebellum and was somewhat 
higher in medulla oblongata and pons in animals that con-
vulsed. In animals fed the Mg-Ca-P= diet, HVA was increased 
(P<0.05) in cerebral cortices from animals that had con-
vulsed and was decreased in the midbrain (Table 18). 
5-HT was significantly increased (P<0.05) in the cere-
bellum and the medulla oblongata and pons of animals that 
had convulsed compared with animals without seizure (Table 
18, overall). Although not statistically significant, 5-HT 
was increased in cerebral cortex and cerebellum (Table 17). 
Its metabolite, 5-HIAA, was consistently (P<0.05) increased 
in cerebral cortex, and medulla oblongata and pons in ani-
mals that had convulsed. This also confirms the observation 
of Poenaru et al. (1984) that 5-HIAA is increased in cere-
bral cortex by magnesium deficient diet (Tables 13 & 17). 
Halaris and UeMet (1978) suggested this may be caused by an 
increased rate of the degradation due to magnesium deficien-
cy and a possible defective uptake of 5-HT which requires 
magnesium. 
Varying dietary calcium levels in magnesium deficient 
diets affected 5-HT concentration, the higher the dietary 
calcium levels, the higher the brain 5-HT concentration as 
deteremined in the overal 1 ANOVA. This is consistent with 
the observation of others (Trulson and Crisp, 1985) that 
high calcium inhibits 5-HT release in the brain although 
\ 
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calcium is required for the monoamine release from the brain 
{Gorbman et al., 1983; Wallach, 1980). 
There was no statistically significant effect of 
varying dietary phosphorus levels in magnesium deficient 
diets on brain neurotransmitters as determined by ANOVA. 
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CONCLUSIONS 
From this research, major alterations in dietary 
calcium:phosphorus ratio were associated with the reduction 
of audiogenic seizure susceptibility in magnesium deficient 
rats. Disappearance of physical symptoms of magnesium defi-
c i ency due to the low calcium (Mg-Ca-P=) diet confirmed 
p evious work (Bernhard, 1982; Forbes, 1963). 
High dietary calcium level increased the severity of 
seizures which is consistent with the finding of Colby and 
Frye (195la, 195lb). The animals also convulsed sponta-
neously. 
High calcium-low phosphorus, and high phosphorus-low 
ca lcium levels in magnesium deficient diets prevented sei-
z ures. The Mg-Ca-P+ diet a l so increased serum magnesium to 
normal concentration. Disappearance of physical symptoms of 
magnesium deficiency was also seen due to these treatment 
diets. 
Morris and O'Del 1 (1963) reported that the rat require-
ment for magnesium is increased when diets are high in cal-
cium or high in phosphorus. This is compatible with the 
observation in this study that seizures were more severe in 
rats fed diets high in both dietary calcium and phosphorus. 
The animals also experienced spontaneous seizures which did 
not occur in rats fed diets deficient in just magnesium 
(Expts I & II; Mg-Ca=P=). 
Magnesium deficient diets decreased serum magnesium 
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concentrations in all treatments but Mg-Ca-P+ compared with 
control diet (Mg=Ca=P=; Tables 9 & 11). 
Serum calcium concentrations were increased in response 
to three diets (Mg-Ca=P=, Mg-Ca=P- and Mg-Ca+P=), decreased 
by Mg-Ca=P+ diet, and unchanged in five diets (Mg-Ca-P=, 
Mg-Ca-P-, Mg-Ca-P+, Mg-Ca+P- and Mg-Ca+P+; Tables 9 & 11). 
Five diets (Mg-Ca=P=, Mg-Ca=P+, Mg-Ca+P=, Mg-Ca+P- and 
Mg-Ca+P+) caused increased serum phosphorus levels. Three 
diets (Mg-Ca-P=, Mg-Ca=P+, and Mg-Ca-P+) caused decreased 
serum potassium levels while four diets (Mg-Ca-P=, Mg-Ca-P-, 
Mg-Ca+P- and Mg-Ca+P+) increased serum sodium levels 
compared with control (Mg=Ca=P=). 
Changes in the serum levels of calcium, phosphorus, po-
tassium, and sodium were not uniquely associated with sei-
zure susceptibility. 
Audiogenic seizure susceptible rats, in general, had 
higher serum mineral concentrations than those which did not 
convulse (Tables 8, 10 & 12). 
Rats that were tested for seizure susceptibility had 
serum minerals higher than untested animals (Table 12). 
Magnesium deficient diets caused increased brain neuro-
transmitter (5-HT, 5-HIAA, and DOPAC) concentrations in the 
cerebral cortex, cerebellum, and medulla oblongata and pons 
(Table 17) compared with the control (Mg=Ca=P=). 
Audiogenic seizure susceptibility caused changes in 
NE, UA, and HVA especially in the Mg-Ca-P= (Table 18). 
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RECOMMENDATIONS 
In this research, the relation between serum mineral 
concentration and audipgenic seizure susceptibility revealed 
that seizures were associated with increased mineral concen-
tration in serum. Determination of CSF mineral concentra-
tion and the activity of (Na+-K+)-ATPase may be beneficial 
in the interpretation of future experiments. 
To prevent the variation of brain neurotransmitters, it 
may be beneficial to collect the samples at the same period 
of time in the day to prevent variations due to circadian 
neurotransmitter metabolism. It should be beneficial to 
study the neurotransmitters in specific areas of the brain, 
such as; hypothalamus, amygdaloid nuclei, caudate nuclei 
(Telencephalic regions), substantia nigra (Mesencephalic 
regions), and some other areas that may be more specifically 
associated with seizure susceptibility. 
In this research, the sodium content was higher in 
high phosphorus diets than in diets of low or normal phos-
phorus levels. Chutkow (1972) reported that magnesium defi-
cient rats with high dietary calcium and high sodium levels 
develop severe audiogenic 
sources of phosphorus salt 
seizure susceptibility. Other 
substitutions may be beneficial 
in controlling dietary sodium levels. 
To minimize the hemolysis of erythrocyte which causes 
an increase in mineral concentration in serum and hemolysis, 
as seen in Experiment I, it may be beneficial to dilute the 
59 
samples the same day as blood is collected or to study min-
eral concentrations in whole blood. 
The study of gamma-amino butyric acid concentration and 
other neurotransmissions of the brain neurons may be helpful 
in the relation to behavioral abnormalities. Analyzing the 
monoamine concentrations in the blood may be beneficial. 
Since some brain neurotransmitter concentrations were 
different in animals that convulsed vs. those that did not, 
it may be beneficial in future studies to analyze the amines 
in magnesium deficiency without testing seizure susceptibil-
ity. Poor correlation between serum mineral and brain neu-
rotransmitter concentrations was observed. Poenaru et al. 
(1985) found a relationship between low serum magnesium 
concentration and increased in OA and 5-HIAA levels. This 
deserves further study to learn if this is true for other 
transmitters and in transmitter levels in brain areas more 
speci fi cal ly associated with seizure suscepti bi I ity. 
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APPENDICES 
Appendix A. Serum mineral 
concentrations for non-
tested animals. 
Experiment I I . 
Mg Ca p K Na Diet mg/dl mg/dl mg/dl mg/dl m9/dl 
Mg=Ca=P= a a 8.2+0.8ab 33.0+5.4ab 240+llab 1.77+0.26 7.2+0.6 - - - -
Mg-Ca=P= b 8.8+1.0bc 8.0+3.lab 31.8+8.6acd 220+12a o. 74+0.12 - - -
Mg-Ca=P- be c 5.4+1.3ac 27.6+3.9aef 247+14ab 0.95+0.16 9. 7+1. 7 - - - -
Mg-Ca-P= 0.91+0.19bd a ad 25.0+2.3agh 258+llb 7.5+0.5 6.6+1.0 - - - - -
Mg-Ca-P- 0.98+0.23be a 5.4+0.8ac 23.5+3.3cegi 263+25b 7.7+0.3 - - -
Mg-Ca=P+ e 4.3+1.0 e 19.2+6.8eg 258+19b 1. 25+0. 21 17.8+7.3 - - - -
Mg-Ca+P= l.10+0.27cdef 8.0+1.0abd 9.7+3.3bcdf 33. 5+3.1 bdfhi 263+llb - -
Mg-Ca-P+ a 5.9+0.8 10.0+2.3bcdf 22.4+2.9egk 262+24b 1. 73+0.53 - - - - -
Mg-Ca+P- l.09+0.23cdef 8.9+1.lcd 5.1+1.0afg 29.9+1.4aijkl 254+24b - - -
Mg-Ca+P+ 0.94+0.lObfg 5.9+1.2 12.3+4.7bde 34.8+10.9bdfl 267+23b - - - - -
LS0(.05/ . 01) 0.21/0.28 0.9/1.l 4.7/6.2 6.9/9.2 22/30 
abcdefghijkl Mean+standard deviation for 5 animals (11 for Mg=Ca=P=). 
Values with the same superscript are not significantly different 
(P<0.01). Mean differences must equal or exceed the Least Significant 
Difference value (LSD) to be statistically significant at the indicated 
levels of probability. 0\ 
I.O 
70 
Aeeendix tL Correlation of 
serum mineral values for 
each treatment di et. 
Diet Mg-Ca Ca-P Mg-P 
Mg-Ca=P=(I) 0.63 0.45 0.20 
( I I ) 0.58 0.40 0.50 
Mg-Ca=P-(I} 0.79 0.55 0.74 
( I I ) 0.47 0.47 0. 7 3 
Mg-Ca-P=(I} 0.83 0.05 0.03 
( I I ) 0. 51 0.54 0.57 
Mg-Ca-P-(I} 0.82 0.60 0.62 
( I I ) 0. 7 7 0.88 0.80 
Mg-Ca=P+ 0.61 -0.31 0.35 
Mg-Ca+P- 0.81 0.89 0.87 
Mg-Ca-P+ 0. 2 5 -0.80 0.05 
Mg-Ca+P- 0.09 -0.45 0. 51 
Mg-Ca+P+ 0. 8 9 0.33 0.59 
( I ) Experiment I. 
( I I ) Experiment I I. 
Appendix C. Brain weight 
(mean±standard deviation, g) 
Diet Cerebral 
Cortex 
Mg=Ca=P= 1.02+0.03 
Mg-Ca=P= 0.99+0.03 
Mg-Ca=P- 0.97~0.03 
Mg-Ca-P= 0.96~0.03 
Mg-Ca-P- 0.96~0.04 
Mg-Ca=P+ 0.93~0.03 
Mg-Ca+P= 0.95~0.02 
Mg-Ca-P+ 0.95~0.05 
Mg-Ca+P- 0.96+0.07 
Mg-Ca+P+ 0.95+0.07 
Midbrain 
0.10+0.03 
0.10+0.02 
0.11+0.04 
0.10+0.03 
0.09+0.02 
0.10+0.03 
0.10+0.02 
0.10+0.02 
0.10+0.03 
0.10+0.02 
Cerebellum 
0.22+0.03 
0.22+0.0l 
0.22+0.0l 
0.20+0.03 
0.21+0.03 
0.21+0.02 
0.21+0.0l 
0.22+0.02 
0.21+0.02 
0.19+0.02 
Medulla & 
Pons 
0.21+0.03 
0.22+0.03 
0.21+0.02 
0.21+0.02 
0.23+0.02 
0.21+0.04 
0.23+0.03 
0.23+0.04 
0.20+0.02 
0.22+0.0l 
Whole 
Brain 
1.59+0.75 
1.31+0.64 
1.50+0.70 
1.32+0.65 ' 
1.44+0.68 
1.44+0.67 
1.51+0.69 
1.56+0.72 
1.40+0.68 
1.30+0.64 
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